← FDA Drug Approvals (Drugs@FDA)

AZACITIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-05-04

Drug application

FDA Application #

ANDA209540

Application type

Abbreviated New Drug Application (Generic)

Brand name

AZACITIDINE

Generic name

Azacitidine

Active ingredients

AZACITIDINE

Dosage form

POWDER

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

CIPLA

First approval

2018-05-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown